title: Interleukin-12: murine models of a potent antitumor agent.
authors.affiliation: Department of Oncology, Hoffmann-La Roche Inc., Nutley, New Jersey 07110, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Brunda
authors.forename: L
authors.initials: L
authors.lastname: Luistro
authors.forename: L
authors.initials: L
authors.lastname: Rumennik
authors.forename: R B
authors.initials: RB
authors.lastname: Wright
authors.forename: J M
authors.initials: JM
authors.lastname: Wigginton
authors.forename: R H
authors.initials: RH
authors.lastname: Wiltrout
authors.forename: J A
authors.initials: JA
authors.lastname: Hendrzak
authors.forename: A V
authors.initials: AV
authors.lastname: Palleroni
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents; D017209:Apoptosis / Q000187:drug effects; D004317:Doxorubicin / Q000008:administration & dosage; D007167:Immunotherapy; D007371:Interferon-gamma / Q000502:physiology; D018664:Interleukin-12 / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000008:administration & dosage; D007694:Killer Cells, Natural / Q000276:immunology; D008546:Melanoma, Experimental / Q000628:therapy; D051379:Mice; D008817:Mice, Mutant Strains; D019001:Nitric Oxide Synthase / Q000502:physiology; D011994:Recombinant Proteins
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; D018664:Interleukin-12; D004317:Doxorubicin; D007371:Interferon-gamma; D019001:Nitric Oxide Synthase